DIN 02269414 — POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP 450 MG; 150 MG
POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP is a solution of Potassium Chloride / Sodium Chloride marketed by BAXTER CORPORATION. The full Potassium Chloride / Sodium Chloride monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02269414
- Brand name
- POTASSIUM CHLORIDE IN SODIUM CHLORIDE INJECTION USP
- Active ingredient
- Potassium Chloride / Sodium Chloride
- Strength
- 450 MG; 150 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- BAXTER CORPORATION
- Health Canada status
- MARKETED
- Drug class
- Electrolyte replenisher (a parenteral solution affecting electrolyte balance)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Potassium Chloride / Sodium Chloride products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00786209 | (20MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP | 150 MG; 900 MG | SOLUTION | BAXTER CORPORATION | MARKETED |
| 00786217 | (40 MMOL/L) POTASSIUM CHLORIDE IN 0.9% SODIUM CHLORIDE INJECTION USP | 900 MG; 300 MG | LIQUID | BAXTER CORPORATION | MARKETED |
| 02299100 | POTASSIUM CHLORIDE 20 MEQ IN 0.9% SODIUM CHLORIDE | 0.9 G; 0.15 G | SOLUTION | ICU MEDICAL CANADA INC | DORMANT |